Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2026-01-22 @ 9:03 PM
Study NCT ID:
NCT03698994
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-03
First Post:
2018-10-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-14
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-03-30
Completion Date Type:
ESTIMATED
First Submit Date:
2018-10-05
First Submit QC Date:
None
Study First Post Date:
2018-10-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-04-20
Results First Submit QC Date:
None
Results First Post Date:
2023-05-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-14
Last Update Post Date:
2025-12-03
Last Update Post Date Type:
ESTIMATED